Hold JPM at neutral weight with active tiered triggers; reject $320/$319.98 wick-stop as fee-for-being-wrong
Active Hold with tiered architecture outperforms both aggressive deployment and passive Hold. Reject the trader's $320/$319.98 wick-stop as a guaranteed stopout fee. Use closing-basis stops respecting ATR: trim trigger requires close below $319.98 on above-average volume AND 2-3 session hold; tactical long stop is closing basis below $313.50 (one ATR buffer). Pre-commit earnings scenarios and enforce -2% relative-to-SPY reassessment trigger so passive Hold does not bleed alpha into Q3 print. The Neutral analyst's tiered structure captures the franchise upside without paying the stop-hunt fee.
| Position | Action |
|---|---|
| Price tags $315-320 zone and closes above $322 | Add 1/3 of target weight with closing-basis stop at $319.98 |
| Daily close above $345 on above-average volume with RSI >45 and MACD contracting (not expanding) | 2% add (Tier 1 add trigger) |
| Daily close above $352.89 (50 SMA reclaim) with RSI >55 and MACD histogram cross to positive | 2-3% add, re-rate to Overweight (Tier 2 add trigger) |
| Sell into strength at $338-340 (10 EMA confluence) | Trim position - distribution opportunity |
| Sell at $346-349 (Bollinger Middle / 50 SMA retest) | Trim position - distribution opportunity |
| Sustained close below $319.98 on above-average volume with 2-3 session hold | 15-20% trim, re-rate to Underweight |
JPMorgan's 9% pullback to $330.83 represents an opportunity, not a warning—the best-run bank with 17.8% ROE and record earnings is undervalued at 13.21x forward P/E in a structurally favorable higher-for-longer rate environment.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 319.98 | neutral |
| close_50_sma | 352.89 | bearish |
| close_10_ema | 340.17 | bearish |
| rsi | 31.62 | bearish |
| macd | -5.08 | bearish |
| macd_signal | -3.08 | bearish |
| macd_histogram | -2.00 | bearish |
| bollinger_lower_band | 330.30 | bearish |
| bollinger_middle_band | 347.95 | neutral |
| bollinger_upper_band | 365.61 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price tags $315-320 zone and closes back above $322 (2-day hold above 200 SMA confirms support)
Then: Add 1/3 of target weight
↩ rebuts: “Bear's technical framework ignores fundamental earnings strength”
EV: +21.2% (to $400+ target from ~$330 entry) · concedes: Short-term technicals are ugly—50 SMA broken, RSI at 31.62, MACD expanding bearishly, close at session low; Near-term path of least resistance could be to 200 SMA at $320; P/B of 2.49x is premium to peers; One-day close at session low is bearish one day at a time
Buying JPM at $330.83 is catching a falling knife, not buying a gift—the Sep-22 institutional breakdown signals regime change, not routine pullback, and fundamental fragility (margin mean reversion, credit cycle lag effects, elevated macro risk) makes the risk/reward unfavorable until price confirms at $300-310.
· concedes: Q2 EPS growth +46.9% YoY is real (though largely base effect from Q1 $4.39B special charge); Polymarket 8% recession probability suggests near-term recession unlikely; FICC revenue will likely be strong in Q3 earnings; First real resistance at $340 (10 EMA) and $347.95 (Bollinger middle) will likely see failed bounce clustering—creating shorting opportunities; Q3 earnings mid-October is the catalyst; if FICC surprises and credit holds, JPM recovers
→ vs conservative: Path-dependent downside toward 300 to 310 if 319.98 fails is approximately 10 percent drawdown, which does not justify missing the 10-12 percent upside scenario backed by Q3 catalyst, FICC tailwinds, and structural re-rating opportunity
→ vs conservative: Waiting for confirmed reversal at 320 with bullish divergence before stepping in means missing the early entry at the accumulation zone; the conservative instinct to cut exposure into high-quality name testing major moving average support in structurally bullish rate environment leads to underperformance
→ vs neutral: Fair value at 13.2 times forward P/E anchored to 10-year average of 11-12 times is intellectually flawed; that historical multiple was set during post-crisis regulatory purgatory when JPM had half the franchise it has today as largest US bank by assets with dominant investment banking and wealth management
→ vs neutral: The neutral framing of fair value essentially prices JPM as a middle-of-the-road bank; it is the premium franchise in the space and deserves a premium multiple that could drive full reversion to upper end of range and beyond on Q3 beat
→ vs neutral: Waiting for the print before acting is equivalent to demanding certainty that does not exist in markets; there is only asymmetric risk-reward with favorable odds, which overwhelmingly favors the upside here
| atr |
| 6.50 |
| neutral |
| close | 330.83 | bearish |
| volume | 9109409 | neutral |
Support: 330.3 · 319.98 · 315 · 317 | Resistance: 340.17 · 347.95 · 352.89
The technical posture is "risk-off" across all measured dimensions with price broken below the 50 SMA (Sep-22) and 10 EMA, MACD bearish cross confirmed and accelerating, RSI in oversold territory without bullish divergence, and price testing/breaching the Bollinger Lower Band at $330.30; the 200 SMA at $319.98 is the only remaining major support and the last line in the sand before a regime change, while ATR has expanded to 6.50 indicating elevated volatility with no capitulation signature yet.
Market Cap
$879.4B
TTM P/E
14.17x
Forward P/E
13.21x
PEG Ratio
1.55
P/B
2.49x
EPS (TTM)
$23.35
Forward EPS
$25.05
Dividend Yield
1.97%
Beta
0.975
Revenue (TTM)
$186.3B
Net Income (TTM)
$63.6B
Profit Margin
34.92%
Operating Margin
50.39%
ROE
17.79%
ROA
1.36%
Book Value/Share
$133.01
Q2 2026 Revenue
$52,852M
Q2 2026 Net Income
$21,155M
Q2 2026 Diluted EPS
$7.70
Q2 2026 NII
$25,511M
Total Assets
$5,015.1B
Stockholders' Equity
$374.6B
Tangible Book Value
$289.3B
Total Debt
$533.0B
Cash & Equivalents
$309.8B
Net Loans
$1,516.3B
Trading Securities
$794.2B
Q2 2026 Dividends Paid
$4.3B
Q2 2026 Buybacks
$6.8B
52-Week High
$366.50
52-Week Low
$279.10
50-Day MA
$353.18
200-Day MA
$321.56
Revenue Growth (Q2 26 vs Q2 25)
+17.8%
NII Growth (Q2 26 vs Q2 25)
+9.9%
EPS Growth (Q2 26 vs Q2 25)
+46.9%
Loan Growth (Q2 26 vs Q2 25)
+9.3%
TBV Growth
+6.2%
Q2 2026 Operating Cash Flow
-$25.3B
Q2 2026 Investing Cash Flow
$6.4B
Q2 2026 Financing Cash Flow
$18.8B
Strengths
Concerns
JPMorgan Chase & Co. (JPM) is the largest U.S. bank by assets ($5.02T) demonstrating exceptional fundamental strength with TTM net income of $63.6B on $186.3B in revenue, a 34.92% profit margin, and 17.79% ROE. Q2 2026 results show revenue of $52.85B (+17.8% YoY), net income of $21.16B, and diluted EPS of $7.70 (highest in trailing five quarters). The bank maintains a fortress balance sheet with $374.6B in equity and $309.8B in cash, while returning substantial capital through ~$17B annualized dividends and ~$30B annualized buybacks. Valuation at 14.17x TTM P/E and 2.49x P/B reflects a deserved premium to peers given its quality, scale, and earnings momentum, though risks remain around credit quality, rate sensitivity, and regulatory capital requirements.
Macro: The defining macro theme is a bond market breakdown driving long-end yields to multi-decade highs, with 30-year Treasury yields at their highest since 2002 and mortgage rates at 7.58%. The Fed is in a higher-for-longer/hiking-leaning stance with zero cuts priced in for 2026 (97% probability on Polymarket). A cooler-than-expected CPI print provided brief relief, but the broader trend resumed. Equities posted September losses but Friday closed with weekly gains on eased oil and Iran/Hormuz deal hopes. Recession odds remain low at 8%, though Zandi warns of lagged economic damage from high rates. The S&P 500 Shiller CAPE crossing 40x signals equity valuation bubble risk.